2897:TSENissin Foods Holdings Co., Ltd. Analysis
Data as of 2026-06-17 - not real-time
¥2,666.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nissin Foods is trading below its 200‑day moving average while the 20‑day SMA sits beneath the 50‑day SMA, indicating a short‑term bearish bias. The RSI hovers around the mid‑range, suggesting neither overbought nor oversold conditions. A bullish MACD histogram coupled with an increasing volume trend points to potential upside momentum building. Fundamentally, the company delivers modest revenue growth and a solid profit margin, with a forward P/E well below the current trailing P/E, implying earnings expansion ahead. The DCF‑derived fair value sits comfortably above the market price, translating to a notable upside potential. Additionally, a dividend yield above 2½ % and a payout ratio under 50 % support a sustainable income stream.
On the longer horizon, Nissin’s diversified geographic footprint across Japan, the United States and China cushions it against localized shocks, while its entrenched brand portfolio underpins stable cash generation. The combination of undervaluation, growth catalysts, and reliable dividend makes the stock an attractive candidate for medium‑ to long‑term investors, despite the near‑term bearish technical backdrop.
On the longer horizon, Nissin’s diversified geographic footprint across Japan, the United States and China cushions it against localized shocks, while its entrenched brand portfolio underpins stable cash generation. The combination of undervaluation, growth catalysts, and reliable dividend makes the stock an attractive candidate for medium‑ to long‑term investors, despite the near‑term bearish technical backdrop.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near 20‑day SMA and support level
- bearish trend direction despite bullish MACD histogram
- increasing volume but limited upside in the near term
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value above market price indicating upside
- forward earnings expansion reflected in lower forward P/E
- sustainable dividend yield supporting total return
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- strong global brand and product diversification
- steady cash generation and manageable debt profile
- blend of growth prospects and value appeal
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin5.76%
P/E Ratio17.1
ROE9.20%
ROA3.37%
Debt/Equity31.36
P/B Ratio1.5
Op. Cash Flow¥80.4B
Free Cash Flow¥-20817625088
Technical Analysis
TrendBearish
RSI46.7
Support¥2,527.00
Resistance¥2,763.50
MA 20¥2,648.20
MA 50¥2,789.92
MA 200¥2,890.15
MACDBullish
VolumeIncreasing
Fear & Greed Index92.29
Valuation
Fair Value¥2,767.33
Target Price¥3,277.27
Upside/Downside22.93%
GradeUndervalued
TypeBlend
Dividend Yield2.57%
Risk Assessment
Beta-0.01
Volatility26.91%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.